It has been a mixed year for Opus Genetics, Inc. insiders: $324,000 bought by one person and $19.3 million sold by seven, so more selling than buying overall.
Gallagher Cam (Director) made the biggest buy, worth around $164,000.
Big money check: 103 institutions held IRD as of Q2 2026, and more funds bought than sold. Zooming out by quarter: 4 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 556,000 | $4.96 | $2.8M | SEC |
| Sep 8, 2026 | Gagnon Robert E. | CFO | Sell | 28,000 | $4.54 | $127K | SEC |
| Jul 27, 2026 | YERXA BENJAMIN R | President | Sell | 7,429 | $2.97 | $22K | SEC |
| Jul 27, 2026 | SCHACHLE JOSEPH K | COO | Sell | 4,644 | $2.94 | $14K | SEC |
| Jul 27, 2026 | Magrath George | CEO | Sell | 9,475 | $2.95 | $28K | SEC |
| Jul 27, 2026 | Gagnon Robert E. | CFO | Sell | 7,783 | $2.95 | $23K | SEC |
| May 20, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | Director | Sell | 1,700,000 | $4.35 | $7.4M | SEC |
| Apr 27, 2026 | YERXA BENJAMIN R | President | Sell | 7,470 | $5.24 | $39K | SEC |
| Apr 27, 2026 | SCHACHLE JOSEPH K | COO | Sell | 4,697 | $5.22 | $25K | SEC |
| Apr 27, 2026 | Zaremba Rabourn Amy | Officer | Sell | 1,641 | $5.20 | $9K | SEC |
| Apr 27, 2026 | Magrath George | CEO | Sell | 9,511 | $5.22 | $50K | SEC |
| Apr 27, 2026 | Jayagopal Ashwath | Executive Officer | Sell | 7,542 | $5.19 | $39K | SEC |
| Apr 27, 2026 | Gagnon Robert E. | CFO | Sell | 7,842 | $5.18 | $41K | SEC |
| Mar 18, 2026 | SCHACHLE JOSEPH K | COO | Sell | 3,719 | $5.25 | $20K | SEC |
| Mar 18, 2026 | Zaremba Rabourn Amy | Officer | Sell | 2,816 | $5.25 | $15K | SEC |
In the last 12 months Opus Genetics, Inc. insiders made open-market purchases worth about $324,000 and sales worth about $19.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in IRD was filed on 2026-10-02.
103 investment managers reported holding IRD in SEC Form 13F filings for Q2 2026.
No congressional trades in IRD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).